Compound Detail
CHEMBL6068496
RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F MRNA 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL6068496 |
| Name | RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION GLYCOPROTEIN F MRNA |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
3
Known Names
2
Indications
1
Mechanisms
Drug Information
| Molecule Type | Vaccine component |
| First Approval | 2024 |
| Availability | Unknown |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Fusion glycoprotein F0 vaccine antigen | VACCINE ANTIGEN | Fusion glycoprotein F0 | ✓ | ✓ |
Indications
Respiratory Syncytial Virus Infections Vaccination
Data from ChEMBL 36 via Core Engine